Patents/Inventors

Laurent Poirot

ParisFR23 patents

17 Patents

US126180482026
Dual CAR-T Cells
Cellectis S.A.
0 cites
US125775812026
Use of Pre T Alpha or Functional Variant Thereof for Expanding TCR Alpha Deficient T Cells
CELLECTIS
0 cites
US125347442026
Methods to Genetically Modify Cells for Delivery of Therapeutic Proteins
CELLECTIS S.A.
0 cites
US123919332025
Targeted Gene Insertion for Improved Immune Cells Therapy
CELLECTIS
0 cites
US123657332025
Method for Improving Production of Car T Cells
Cellectis
0 cites
US122526992025
Method for Generating T-cells Compatible for Allogenic Transplantation
CELLECTIS
0 cites
US122214782025
Targeted Gene Integration of CRS Inhibitor Genes for Improved Immune Cells Therapy
CELLECTIS
0 cites
US122091252025
Targeted Gene Integration of NK Inhibitors Genes for Improved Immune Cells Therapy
CELLECTIS
0 cites
US121718202024
Method for Generating Immune Cells Resistant to Arginine And/or Tryptophan Depleted Microenvironment
CELLECTIS
0 cites
US121448252024
Cellular Immunotherapy for Repetitive Administration
CELLECTIS
0 cites
US119590912024
Methods for Engineering T Cells for Immunotherapy by Using Rna-guided Cas Nuclease System
Cellectis
0 cites
US119039682024
Engineered Immune Cells Resistant to Tumor Microenvironment
CELLECTIS
0 cites
US118916142024
Methods for Engineering Allogeneic and Immunosuppressive Resistant T Cell for Immunotherapy
CELLECTIS
0 cites
US118735112024
Targeted Gene Insertion for Improved Immune Cells Therapy
CELLECTIS
0 cites
US118209962023
Method for Generating T-cells Compatible for Allogenic Transplantation
CELLECTIS
0 cites
US116921692023
Cells for Immunotherapy Engineered for Targeting Antigen Present Both on Immune Cells and Pathological Cells
CELLECTIS
0 cites
US116035392023
Methods for Engineering Allogeneic and Immunosuppressive Resistant T Cell for Immunotherapy
CELLECTIS
0 cites